JP2026071342A5 - - Google Patents
Info
- Publication number
- JP2026071342A5 JP2026071342A5 JP2026017958A JP2026017958A JP2026071342A5 JP 2026071342 A5 JP2026071342 A5 JP 2026071342A5 JP 2026017958 A JP2026017958 A JP 2026017958A JP 2026017958 A JP2026017958 A JP 2026017958A JP 2026071342 A5 JP2026071342 A5 JP 2026071342A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- antigen
- binding protein
- items
- following positions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010663029 | 2020-07-10 | ||
| CN202010663029.3 | 2020-07-10 | ||
| CN202110750959.7 | 2021-07-01 | ||
| CN202110750959 | 2021-07-01 | ||
| PCT/CN2021/105620 WO2022007965A1 (zh) | 2020-07-10 | 2021-07-09 | 一种抗IgE的工程化抗体及其应用 |
| JP2023501419A JP2023541217A (ja) | 2020-07-10 | 2021-07-09 | 抗IgE改変抗体及びその適用 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023501419A Division JP2023541217A (ja) | 2020-07-10 | 2021-07-09 | 抗IgE改変抗体及びその適用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2026071342A JP2026071342A (ja) | 2026-04-28 |
| JP2026071342A5 true JP2026071342A5 (cg-RX-API-DMAC7.html) | 2026-05-11 |
Family
ID=79552269
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023501419A Ceased JP2023541217A (ja) | 2020-07-10 | 2021-07-09 | 抗IgE改変抗体及びその適用 |
| JP2026017958A Pending JP2026071342A (ja) | 2020-07-10 | 2026-02-05 | 抗IgE改変抗体及びその適用 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023501419A Ceased JP2023541217A (ja) | 2020-07-10 | 2021-07-09 | 抗IgE改変抗体及びその適用 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230250191A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4180454A4 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2023541217A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230042030A (cg-RX-API-DMAC7.html) |
| CN (1) | CN116018352A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021306786A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112023000400A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3185192A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL299747A (cg-RX-API-DMAC7.html) |
| TW (1) | TWI896700B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022007965A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL318098A (en) | 2022-07-01 | 2025-02-01 | Alk Abell? As | IGE-FCER pushers |
| CN116143932B (zh) * | 2022-12-07 | 2025-02-11 | 南开大学 | 一种针对IgE的抗体或其抗原结合片段以及Fc变体 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1260521B1 (en) | 1991-08-14 | 2007-11-21 | Genentech Inc. | Immunoglobulin variants for specific Fc epsilon receptors |
| CA2226575C (en) | 1995-07-27 | 2011-10-18 | Genentech, Inc. | Stabile isotonic lyophilized protein formulation |
| US6267958B1 (en) | 1995-07-27 | 2001-07-31 | Genentech, Inc. | Protein formulation |
| ZA966075B (en) | 1995-07-27 | 1998-01-19 | Genentech Inc | Protein formulation. |
| US5994511A (en) * | 1997-07-02 | 1999-11-30 | Genentech, Inc. | Anti-IgE antibodies and methods of improving polypeptides |
| US20030190598A1 (en) | 2000-05-26 | 2003-10-09 | Jasmid Tanha | Single-domain antigen-binding antibody fragments derived from llama antibodies |
| NZ601815A (en) * | 2008-03-31 | 2014-10-31 | Genentech Inc | Compositions and methods for treating and diagnosing asthma |
| US20180273626A1 (en) * | 2015-09-11 | 2018-09-27 | The Board Of Trustees Of The Leland Stanford Junio University | Omalizumab resistant ige variants and their use in anti-ige therapy |
| GB201610198D0 (en) * | 2016-06-10 | 2016-07-27 | Ucb Biopharma Sprl | Anti-ige antibodies |
| EP4342541A3 (en) * | 2017-04-07 | 2024-07-03 | Kookmin University Industry Academy Cooperation Foundation | Antibody fc variants for increased blood half-life |
| KR20220098056A (ko) * | 2018-02-09 | 2022-07-08 | 제넨테크, 인크. | 비만 세포 매개 염증성 질환에 대한 치료 및 진단 방법 |
| EP3788078A4 (en) * | 2018-05-04 | 2022-03-02 | Allakos Inc. | METHODS AND COMPOSITIONS FOR THE TREATMENT OF CHRONIC URTICARIA |
-
2021
- 2021-07-09 EP EP21836979.1A patent/EP4180454A4/en active Pending
- 2021-07-09 KR KR1020237003490A patent/KR20230042030A/ko active Pending
- 2021-07-09 CA CA3185192A patent/CA3185192A1/en active Pending
- 2021-07-09 IL IL299747A patent/IL299747A/en unknown
- 2021-07-09 JP JP2023501419A patent/JP2023541217A/ja not_active Ceased
- 2021-07-09 BR BR112023000400A patent/BR112023000400A2/pt unknown
- 2021-07-09 US US18/004,959 patent/US20230250191A1/en active Pending
- 2021-07-09 WO PCT/CN2021/105620 patent/WO2022007965A1/zh not_active Ceased
- 2021-07-09 AU AU2021306786A patent/AU2021306786A1/en active Pending
- 2021-07-09 TW TW110125327A patent/TWI896700B/zh active
- 2021-07-09 CN CN202180049003.2A patent/CN116018352A/zh active Pending
-
2026
- 2026-02-05 JP JP2026017958A patent/JP2026071342A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10442857B2 (en) | Anti-IL-17 antibodies | |
| CN106102837B (zh) | 双特异性hiv-1-中和抗体 | |
| ES2567198T3 (es) | Antagonistas de la IL-1 beta humana | |
| RU2004117915A (ru) | Модифицированное анти-tnf альфа антитело | |
| CN101679507A (zh) | 结晶抗人类il-12抗体 | |
| AU2018398341B2 (en) | Monoclonal antibodies and methods for using same | |
| TW201620935A (zh) | 基於vl和vнн可變區衍生物的高親和力抗聚集抗體 | |
| TW200835699A (en) | Crystalline anti-hTNFalpha antibodies | |
| TWI859623B (zh) | Il10單體融合蛋白及其應用 | |
| CN106039306A (zh) | 使用针对TNFα的单结构域抗体治疗免疫病症的方法 | |
| TW200812616A (en) | Binding polypeptides with optimized scaffolds | |
| TR201808057T4 (tr) | Il-17 antagonistik antikorları. | |
| TWI797400B (zh) | 抗IL17a抗體的水性藥物組合物及其用途 | |
| CN104327187A (zh) | 一种重组人GLP-1-Fc融合蛋白 | |
| BRPI1013341B1 (pt) | Variantes de domínio variável único de imunoglobulina anti-albumina de soro, ligante multiespecífico e composição que compreendem as ditas variantes, bem como ácidos nucleicos e vetor | |
| JP2025512865A5 (cg-RX-API-DMAC7.html) | ||
| WO2021052307A1 (zh) | 一种抗b7-h3抗体及其应用 | |
| JP2003502024A (ja) | タンパク質骨格および単量体ポリペプチドを多量体化するためのその使用 | |
| US20250388684A1 (en) | Anti-ccr8 antibody and use thereofr | |
| JP2023541217A5 (cg-RX-API-DMAC7.html) | ||
| RU2656160C2 (ru) | Антитело или его антигенсвязывающий фрагмент, способный связываться с рецептором интерлейкина-6 человека | |
| CN114805578A (zh) | 一种白细胞免疫球蛋白样受体亚家族b成员2的羊驼纳米抗体、制备方法及其应用 | |
| CN116018352A (zh) | 一种抗IgE的工程化抗体及其应用 | |
| TW201444576A (zh) | 具有降低黏度的調配物 | |
| CN104744592A (zh) | 抗HER2-抗CD3 scFv双特异四价抗体 |